Sabiedrība ar ierobežotu atbildību "IMEDPHARM"Active
Key figures
Ratios
2025Balance sheet structure
Dividends
calculatedPaid out in dividends approximately 85 146 € (97% of equity at the end of the previous year).
Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).
Summary of financial statements2010–2025
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||||||||||||
| Total current assets | 131 455 | 234 011 | 211 069 | 73 861 | 335 461 | 215 731 | 44 754 | 62 538 | 237 323 | 253 668 | 382 183 | 388 814 | 339 894 | 267 656 | 251 724 | 330 734 |
| Total non-current assets | 2194 | 14 313 | 15 935 | 6534 | 13 742 | 29 602 | 24 353 | 16 000 | 22 724 | 16 844 | 10 210 | 10 586 | 17 330 | 13 419 | 42 745 | 27 204 |
| Total assets | 133 649 | 248 324 | 227 004 | 80 395 | 349 203 | 245 333 | 69 107 | 78 538 | 260 047 | 270 512 | 392 393 | 399 400 | 357 224 | 281 075 | 294 469 | 357 938 |
| Balance sheet — liabilities and equity | ||||||||||||||||
| Current liabilities | 118 742 | 119 893 | 134 573 | 30 178 | 299 402 | 212 255 | 27 816 | 45 031 | 105 771 | 41 099 | 13 679 | 75 774 | 56 831 | 57 056 | 53 976 | 119 183 |
| Non-current liabilities | 0 | 0 | 0 | 0 | 0 | 2565 | 36 521 | 21 773 | 148 842 | 218 276 | 108 884 | 34 484 | 106 543 | 91 833 | 152 502 | 149 233 |
| Total liabilities | 118 742 | 119 893 | 134 573 | 30 178 | 299 402 | 214 820 | 64 337 | 66 804 | 254 613 | 259 375 | 122 563 | 110 258 | 163 374 | 148 889 | 206 478 | 268 416 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | 12 907 | 113 524 | -22 469 | -7261 | 45 147 | 25 706 | 1925 | 6964 | 1256 | 5703 | 266 985 | 251 191 | 10 582 | 38 435 | 71 306 | 86 677 |
| Total equity | 14 907 | 128 431 | 91 531 | 49 270 | 47 993 | 28 552 | 4770 | 11 734 | 5434 | 11 137 | 269 830 | 289 142 | 193 850 | 132 186 | 87 991 | 89 522 |
| Income statement | ||||||||||||||||
| Sales revenue | 1 002 283 | 1 268 898 | 673 172 | 520 564 | 1 560 155 | 1 176 725 | 1 382 409 | 507 259 | 800 205 | 1 236 717 | 2 332 551 | 3 436 278 | 1 382 073 | 1 444 468 | 1 232 450 | 1 566 205 |
| Operating profit | 15 001 | 134 099 | -16 516 | -7261 | 53 209 | 28 670 | 1925 | 9524 | 1256 | 5703 | 266 985 | 251 191 | 49 457 | 63 460 | 100 181 | 125 281 |
| Profit before income tax | 15 001 | 134 068 | -16 516 | -7261 | 53 209 | 28 670 | 1925 | 9524 | 1256 | 5703 | 266 985 | 251 191 | 49 457 | 63 460 | 100 181 | 125 281 |
| Profit for the reporting year | 12 907 | 113 524 | -22 469 | -7261 | 45 147 | 25 706 | 1925 | 6964 | 1256 | 5703 | 266 985 | 251 191 | 10 582 | 38 435 | 71 306 | 86 677 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | ||||||||||||||||
| Employees | 2 | 2 | 2 | 3 | 4 | 4 | 5 | 5 | 3 | 4 | 4 | 5 | 7 | 5 | 5 | 5 |
| Calculated dividend | — | 0 | 14 431 | 35 000 | 46 424 | 45 147 | 25 707 | 0 | 7556 | 0 | 8292 | 231 879 | 105 874 | 100 099 | 115 501 | 85 146 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Related companies
Summary: Sabiedrība ar ierobežotu atbildību "IMEDPHARM"
Overview
Sabiedrība ar ierobežotu atbildību "IMEDPHARM" (reg. no. 40103257298) is a limited liability company. The company was registered in 2009 and has been in the register for 16 years. Registered address: Rīga, Graudu iela 55.
Financial results
Revenue in 2025 was 1 566 205 €, up 27,1% on the previous year (1 232 450 €). From 2010 to 2025, revenue grew by an average of 3,0% per year. Net profit for 2025 was 86 677 € (5,5% of revenue). The company was profitable in 14 of the 16 published years. In 2025 the company had 5 employees. Revenue per employee was 313 241 €. At the end of 2025, total assets were 357 938 € and equity 89 522 € (25,0% of assets).
Management and owners
The company has one board member. The sole owner of the company is a private individual.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.